Symbols / ONCO $1.53 +0.66% Onconetix, Inc.

Healthcare • Biotechnology • United States • NCM
ONCO Chart
About

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 1.10M
Enterprise Value -4.08M Income -15.53M Sales 815.37K
Book/sh 50.53 Cash/sh 7.28 Dividend Yield —
Payout 0.00% Employees 2 IPO —
P/E 0.00 Forward P/E -1.80 PEG —
P/S 1.35 P/B 0.03 P/C —
EV/EBITDA 0.65 EV/Sales -5.01 Quick Ratio 0.61
Current Ratio 0.66 Debt/Eq 0.31 LT Debt/Eq —
EPS (ttm) -82.80 EPS next Y -0.85 EPS Growth —
Revenue Growth -57.40% Earnings 2023-11-17 17:00 ROA -14.93%
ROE -115.46% ROIC — Gross Margin 77.62%
Oper. Margin -4.22% Profit Margin 0.00% Shs Outstand 692.93K
Shs Float 653.84K Short Float 7.28% Short Ratio 0.56
Short Interest — 52W High 74.38 52W Low 1.17
Beta 3.63 Avg Volume 1.37M Volume 602.10K
Target Price — Recom None Prev Close $1.52
Price $1.53 Change 0.66%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.53
Latest analyst target
3. DCF / Fair value
$-116.76
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.53
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-09-13 down Maxim Group Buy → Hold —
2023-04-26 main HC Wainwright & Co. — → Buy $9
2023-02-01 reit HC Wainwright & Co. — → Buy $7
2022-12-09 init HC Wainwright & Co. — → Buy $7
2022-12-08 init Maxim Group — → Buy $4
News
RSS: Latest ONCO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-08-15 TARSH SIMON Director — 618 $0.00 $0
2025-08-15 RAMDEEN TIMOTHY R. Director — 618 $0.00 $0
2025-08-15 MEIER THOMAS PH.D. Director — 618 $0.00 $0
2025-08-15 OAKLEY ANDREW J. Director — 618 $0.00 $0
2025-03-21 OAKLEY ANDREW J. Director — 1,709 $0.00 $0
2024-12-20 BRUHLMANN CHRISTIAN Officer — 177,462 $0.00 $0
2024-12-20 SCHIESS RALPH Chief Executive Officer — 177,462 $0.00 $0
2024-09-26 SAPIRSTEIN JAMES E Director — 3,318 $0.00 $0
2024-09-26 TARSH SIMON Director — 3,318 $0.00 $0
2024-09-26 RAMDEEN TIMOTHY R. Director — 3,318 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.82
-67.70%
2.52
+4217.31%
0.06
0.00
Operating Revenue
0.82
-67.70%
2.52
+4217.31%
0.06
0.00
Cost Of Revenue
0.18
-87.58%
1.47
+23.90%
1.19
0.00
Reconciled Cost Of Revenue
0.18
-87.58%
1.47
+23.90%
1.19
0.00
Gross Profit
0.63
-40.01%
1.06
+193.61%
-1.13
0.00
Operating Expense
6.98
-38.72%
11.39
-31.90%
16.72
+24.02%
13.48
Research And Development
-0.07
-142.84%
0.15
-92.08%
1.95
-52.80%
4.13
Selling General And Administration
7.04
-37.29%
11.23
-23.96%
14.77
+57.95%
9.35
General And Administrative Expense
7.04
-37.29%
11.23
-23.96%
14.77
+57.95%
9.35
Other Gand A
7.04
-37.29%
11.23
-23.96%
14.77
+57.95%
9.35
Total Expenses
7.16
-44.30%
12.86
-28.21%
17.91
+32.82%
13.48
Operating Income
-6.34
+38.59%
-10.33
+42.11%
-17.85
-32.39%
-13.48
Total Operating Income As Reported
-17.86
+68.39%
-56.49
-56.76%
-36.03
-167.29%
-13.48
EBITDA
-13.27
+76.97%
-57.60
-56.91%
-36.71
-173.66%
-13.41
Normalized EBITDA
-3.17
+75.00%
-12.69
+29.25%
-17.94
-33.12%
-13.47
Reconciled Depreciation
0.02
-97.93%
0.73
+1564.53%
0.04
+550.73%
0.01
EBIT
-13.28
+77.23%
-58.33
-58.71%
-36.75
-173.85%
-13.42
Total Unusual Items
-10.09
+77.52%
-44.91
-139.26%
-18.77
-30663.94%
0.06
Total Unusual Items Excluding Goodwill
-10.09
+77.52%
-44.91
-139.26%
-18.77
-30663.94%
0.06
Special Income Charges
-15.95
+65.44%
-46.16
-147.13%
-18.68
0.00
Other Special Charges
4.44
—
0.49
—
Impairment Of Capital Assets
11.51
-72.99%
42.63
0.00
—
Write Off
0.00
-100.00%
3.53
-80.59%
18.19
0.00
Net Income
-14.03
+76.09%
-58.69
-56.89%
-37.41
-178.76%
-13.42
Pretax Income
-14.03
+76.51%
-59.74
-59.63%
-37.42
-178.86%
-13.42
Net Non Operating Interest Income Expense
-0.75
+46.65%
-1.41
-109.59%
-0.67
0.00
Interest Expense Non Operating
0.75
-46.65%
1.41
+109.59%
0.67
0.00
Net Interest Income
-0.75
+46.65%
-1.41
-109.59%
-0.67
0.00
Interest Expense
0.75
-46.65%
1.41
+109.59%
0.67
0.00
Interest Income Non Operating
0.00
-88.89%
0.00
0.00
—
Interest Income
0.00
-88.89%
0.00
0.00
—
Other Income Expense
-6.94
+85.55%
-48.00
-153.91%
-18.90
-30882.30%
0.06
Other Non Operating Income Expenses
3.16
+202.18%
-3.09
-2204.44%
-0.13
—
Gain On Sale Of Security
5.86
+368.49%
1.25
+1459.69%
-0.09
-249.76%
0.06
Tax Provision
0.00
+100.05%
-1.05
-8199.69%
-0.01
0.00
Tax Rate For Calcs
0.00
+1100.00%
0.00
+5092.88%
0.00
0.00
Tax Effect Of Unusual Items
-2.12
-169.72%
-0.79
-12342.43%
-0.01
0.00
Net Income Including Noncontrolling Interests
-14.03
+76.09%
-58.69
-56.89%
-37.41
-178.76%
-13.42
Net Income From Continuing Operation Net Minority Interest
-14.03
+76.09%
-58.69
-56.89%
-37.41
-178.76%
-13.42
Net Income From Continuing And Discontinued Operation
-14.03
+76.09%
-58.69
-56.89%
-37.41
-178.76%
-13.42
Net Income Continuous Operations
-14.03
+76.09%
-58.69
-56.89%
-37.41
-178.76%
-13.42
Normalized Income
-6.06
+58.42%
-14.57
+21.86%
-18.65
-38.32%
-13.48
Net Income Common Stockholders
-15.53
+73.63%
-58.90
-57.44%
-37.41
-176.78%
-13.52
Diluted EPS
-82.80
+99.09%
-9,116.95
+75.47%
-37,166.25
-146.65%
-15,068.22
Basic EPS
-82.80
+99.09%
-9,116.95
+75.47%
-37,166.25
-146.65%
-15,068.22
Basic Average Shares
0.19
+2803.07%
0.01
+542.15%
0.00
+12.15%
0.00
Diluted Average Shares
0.19
+2803.07%
0.01
+542.15%
0.00
+12.15%
0.00
Diluted NI Availto Com Stockholders
-15.53
+73.63%
-58.90
-57.44%
-37.41
-176.78%
-13.52
Preferred Stock Dividends
1.50
+626.05%
0.21
—
0.10
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
24.93
-11.55%
28.18
-67.80%
87.52
+232.64%
26.31
Current Assets
6.07
+538.43%
0.95
-83.72%
5.84
-77.77%
26.26
Cash Cash Equivalents And Short Term Investments
5.22
+707.53%
0.65
-85.80%
4.55
-82.32%
25.75
Cash And Cash Equivalents
5.22
+707.53%
0.65
-85.80%
4.55
-82.32%
25.75
Cash Financial
5.22
+707.53%
0.65
-85.80%
4.55
-82.32%
25.75
Receivables
0.39
+303.78%
0.10
-35.68%
0.15
+317.66%
0.04
Accounts Receivable
0.30
+1054.36%
0.03
-82.82%
0.15
0.00
Other Receivables
0.06
+43.53%
0.04
—
—
Taxes Receivable
0.03
+11.12%
0.03
0.00
—
Inventory
0.15
+134.03%
0.06
-82.40%
0.36
0.00
Raw Materials
0.10
+80.05%
0.06
-58.73%
0.14
0.00
Work In Process
—
0.00
-100.00%
0.19
0.00
Finished Goods
0.05
+601.49%
0.01
-77.92%
0.03
0.00
Prepaid Assets
0.31
+114.32%
0.14
-81.38%
0.77
+64.13%
0.47
Current Deferred Assets
—
—
—
0.00
Total Non Current Assets
18.86
-30.74%
27.23
-66.66%
81.68
+154872.41%
0.05
Net PPE
0.09
-52.91%
0.18
-12.85%
0.21
+1384.82%
0.01
Gross PPE
0.09
-52.91%
0.18
-12.85%
0.21
+1384.82%
0.01
Other Properties
0.09
-52.91%
0.18
-12.85%
0.21
+1384.82%
0.01
Goodwill And Other Intangible Assets
18.55
-31.42%
27.05
-66.64%
81.09
0.00
Goodwill
18.55
-31.42%
27.05
-51.42%
55.68
0.00
Other Intangible Assets
—
—
25.41
—
Non Current Deferred Assets
0.23
0.00
-100.00%
0.37
0.00
Non Current Prepaid Assets
—
0.00
-100.00%
0.02
-54.88%
0.04
Total Liabilities Net Minority Interest
9.16
-50.67%
18.57
-78.43%
86.11
+2095.41%
3.92
Current Liabilities
9.14
-50.05%
18.29
+6.40%
17.19
+338.25%
3.92
Payables And Accrued Expenses
2.06
-76.11%
8.61
+22.91%
7.01
+152.47%
2.78
Payables
1.84
-76.89%
7.95
+48.45%
5.36
+219.38%
1.68
Accounts Payable
1.76
-53.59%
3.79
-28.47%
5.30
+253.17%
1.50
Current Accrued Expenses
0.22
-66.82%
0.66
-59.92%
1.65
+50.34%
1.10
Employee Benefits
0.00
-100.00%
0.28
-49.51%
0.56
0.00
Pensionand Other Post Retirement Benefit Plans Current
0.04
-77.41%
0.19
-61.66%
0.49
-56.96%
1.13
Total Tax Payable
0.08
+100.00%
0.04
-33.92%
0.06
-65.92%
0.18
Current Debt And Capital Lease Obligation
0.02
-99.74%
9.45
-2.53%
9.69
—
Current Debt
—
9.33
-3.02%
9.62
—
Other Current Borrowings
—
9.33
-3.02%
9.62
—
Current Capital Lease Obligation
0.02
-79.56%
0.12
+60.84%
0.07
0.00
Other Current Liabilities
7.01
+16173.15%
0.04
+1531.54%
0.00
-81.16%
0.01
Total Non Current Liabilities Net Minority Interest
0.02
-91.33%
0.28
-99.59%
68.92
0.00
Long Term Debt And Capital Lease Obligation
0.02
0.00
-100.00%
0.19
0.00
Long Term Debt
—
—
0.12
—
Long Term Capital Lease Obligation
0.02
0.00
-100.00%
0.07
0.00
Non Current Pension And Other Postretirement Benefit Plans
0.00
-100.00%
0.28
-49.51%
0.56
0.00
Tradeand Other Payables Non Current
—
0.00
0.00
0.00
Non Current Deferred Liabilities
—
0.00
-100.00%
3.07
0.00
Non Current Deferred Taxes Liabilities
—
0.00
-100.00%
3.07
0.00
Other Non Current Liabilities
—
—
0.86
—
Preferred Securities Outside Stock Equity
—
0.00
-100.00%
64.24
0.00
Stockholders Equity
15.77
+64.05%
9.61
+271.55%
-5.60
-125.02%
22.39
Common Stock Equity
15.76
+84.54%
8.54
+252.49%
-5.60
-125.02%
22.39
Capital Stock
0.00
-99.84%
1.07
+17798716.67%
0.00
-96.18%
0.00
Common Stock
0.00
+1400.00%
0.00
-83.33%
0.00
-96.18%
0.00
Preferred Stock
0.00
-99.84%
1.07
0.00
0.00
Share Issued
0.31
+1026.99%
0.03
+1961.58%
0.00
+45.35%
0.00
Ordinary Shares Number
0.31
+1028.11%
0.03
+2006.40%
0.00
+46.38%
0.00
Treasury Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
+11.11%
0.00
Additional Paid In Capital
147.84
+15.65%
127.83
+158.60%
49.43
+16.77%
42.33
Retained Earnings
-131.21
-13.43%
-115.68
-103.72%
-56.79
-193.07%
-19.38
Gains Losses Not Affecting Retained Earnings
-0.23
+91.52%
-2.72
-214.38%
2.38
0.00
Treasury Stock
0.63
+0.00%
0.63
+0.00%
0.63
+10.41%
0.57
Minority Interest
—
0.00
-100.00%
7.01
0.00
Other Equity Adjustments
-0.23
+91.52%
-2.72
—
—
Total Equity Gross Minority Interest
15.77
+64.05%
9.61
+584.28%
1.40
-93.73%
22.39
Total Capitalization
15.77
+64.05%
9.61
+275.27%
-5.48
-124.49%
22.39
Working Capital
-3.07
+82.30%
-17.34
-52.75%
-11.35
-150.83%
22.34
Invested Capital
15.76
-11.79%
17.87
+332.16%
4.14
-81.53%
22.39
Total Debt
0.05
-99.48%
9.45
-4.43%
9.89
0.00
Net Debt
—
8.68
+67.50%
5.18
—
Capital Lease Obligations
0.05
-59.16%
0.12
-19.60%
0.15
0.00
Net Tangible Assets
-2.78
+84.04%
-17.44
+79.88%
-86.69
-487.21%
22.39
Tangible Book Value
-2.78
+84.95%
-18.51
+78.65%
-86.69
-487.21%
22.39
Current Notes Payable
0.00
-100.00%
9.33
—
—
Duefrom Related Parties Current
—
—
0.00
-100.00%
0.04
Dueto Related Parties Current
0.00
-100.00%
4.12
0.00
—
Dueto Related Parties Non Current
—
0.00
-100.00%
0.86
0.00
Interest Payable
0.00
-100.00%
0.14
0.00
—
Other Equity Interest
—
-0.25
—
—
Preferred Stock Equity
0.00
-99.84%
1.07
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-9.68
+7.79%
-10.50
+22.72%
-13.58
-56.54%
-8.68
Cash Flow From Continuing Operating Activities
-9.68
+7.79%
-10.50
+22.72%
-13.58
-56.54%
-8.68
Net Income From Continuing Operations
-14.03
+76.09%
-58.69
-56.89%
-37.41
-178.76%
-13.42
Depreciation Amortization Depletion
0.02
-97.93%
0.73
+1564.53%
0.04
+550.73%
0.01
Depreciation
—
—
—
0.01
Depreciation And Amortization
0.02
-97.93%
0.73
+1564.53%
0.04
+550.73%
0.01
Other Non Cash Items
-3.75
-185.35%
4.40
+167.75%
1.64
+522.16%
0.26
Pension And Employee Benefit Expense
-0.62
-1179.14%
-0.05
-448.99%
0.01
0.00
Stock Based Compensation
0.07
-83.07%
0.44
+33.02%
0.33
-83.30%
1.97
Provisionand Write Offof Assets
—
0.00
-100.00%
1.15
—
Asset Impairment Charge
11.51
-75.25%
46.51
+152.05%
18.45
0.00
Deferred Tax
0.00
+100.00%
-1.05
-8199.70%
-0.01
0.00
Deferred Income Tax
0.00
+100.00%
-1.05
-8199.70%
-0.01
0.00
Operating Gains Losses
-1.08
+17.18%
-1.30
-317.99%
0.60
+1070.27%
-0.06
Gain Loss On Investment Securities
-5.86
-368.49%
-1.25
-1459.69%
0.09
+249.76%
-0.06
Gain Loss On Sale Of PPE
0.02
0.00
—
0.00
Change In Working Capital
-2.42
-56.97%
-1.54
-194.97%
1.62
-36.61%
2.56
Change In Receivables
-0.32
-373.14%
0.12
+287.32%
-0.06
0.00
Changes In Account Receivables
-0.27
-330.28%
0.12
+287.32%
-0.06
0.00
Change In Inventory
-0.07
-18.38%
-0.06
+80.28%
-0.32
0.00
Change In Prepaid Assets
-0.13
-112.61%
1.02
+346.75%
-0.41
-75.81%
-0.23
Change In Payables And Accrued Expense
-1.67
+35.78%
-2.61
-207.22%
2.43
-14.23%
2.83
Change In Accrued Expense
-0.58
+48.63%
-1.13
-19.85%
-0.94
-154.15%
1.74
Change In Payable
-1.09
+25.96%
-1.48
-143.80%
3.37
+208.31%
1.09
Change In Account Payable
-1.09
+25.96%
-1.48
-143.80%
3.37
+208.31%
1.09
Change In Other Working Capital
-0.23
—
—
—
Change In Other Current Assets
0.00
+100.00%
-0.01
+54.10%
-0.02
+56.28%
-0.04
Investing Cash Flow
0.00
+100.00%
-0.03
+99.67%
-8.65
-26377.99%
-0.03
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-0.03
+99.67%
-8.65
-26377.99%
-0.03
Net PPE Purchase And Sale
0.00
+100.00%
-0.03
+48.28%
-0.06
-489.40%
-0.01
Purchase Of PPE
0.00
+100.00%
-0.03
+48.28%
-0.06
-489.40%
-0.01
Capital Expenditure
—
-0.03
+48.28%
-0.06
-489.40%
-0.01
Net Business Purchase And Sale
—
0.00
-100.00%
1.06
0.00
Net Other Investing Changes
—
—
-9.65
-41272.58%
-0.02
Financing Cash Flow
14.45
+114.33%
6.74
+551.47%
1.04
-96.82%
32.53
Cash Flow From Continuing Financing Activities
14.45
+114.33%
6.74
+551.47%
1.04
-96.82%
32.53
Net Issuance Payments Of Debt
-5.78
-258.04%
3.65
+465.45%
-1.00
0.00
Issuance Of Debt
1.34
-73.28%
5.00
0.00
—
Repayment Of Debt
-7.11
-428.53%
-1.35
-34.55%
-1.00
0.00
Long Term Debt Issuance
1.34
-73.28%
5.00
0.00
—
Long Term Debt Payments
-7.11
-428.53%
-1.35
-34.55%
-1.00
0.00
Net Long Term Debt Issuance
-5.78
-258.04%
3.65
+465.45%
-1.00
0.00
Net Common Stock Issuance
6.39
+833.55%
0.68
+1260.65%
-0.06
-100.17%
34.30
Common Stock Payments
-0.00
-28.97%
-0.00
+98.78%
-0.06
+89.59%
-0.57
Repurchase Of Capital Stock
-1.71
-238687.74%
-0.00
+98.78%
-0.06
+89.59%
-0.57
Proceeds From Stock Option Exercised
0.00
-100.00%
0.01
+1276.47%
0.00
-85.15%
0.00
Net Other Financing Charges
—
-0.40
-95.03%
-0.21
+88.43%
-1.77
Changes In Cash
4.77
+226.26%
-3.78
+82.16%
-21.19
-188.96%
23.82
Effect Of Exchange Rate Changes
-0.20
-58.02%
-0.13
-3702.40%
-0.00
0.00
Beginning Cash Position
0.65
-85.80%
4.55
-82.32%
25.75
+1235.39%
1.93
End Cash Position
5.22
+707.53%
0.65
-85.80%
4.55
-82.32%
25.75
Free Cash Flow
-9.68
+8.04%
-10.52
+22.82%
-13.64
-57.01%
-8.68
Interest Paid Supplemental Data
0.77
+101.98%
0.38
0.00
—
Common Stock Issuance
6.39
+832.70%
0.69
0.00
-100.00%
34.87
Issuance Of Capital Stock
21.94
+529.99%
3.48
+51.52%
2.30
-93.41%
34.87
Net Preferred Stock Issuance
13.84
+394.60%
2.80
+21.71%
2.30
0.00
Preferred Stock Issuance
15.55
+455.85%
2.80
+21.71%
2.30
0.00
Preferred Stock Payments
-1.71
0.00
—
—
Sale Of Business
—
0.00
-100.00%
1.06
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category